Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs aimed toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where remedy choices remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline We https://financefeeds.com/audusd-technical-analysis-report-17-february-2025/